3880 — Medtide Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.16bn
- HK$1.96bn
- CNY570.09m
Annual cashflow statement for Medtide, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 67.6 | 62 | 78.4 | 251 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 52.7 | 32.6 | 68.6 | -16.5 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -11.4 | -36.1 | -56.6 | 3.9 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 135 | 88.3 | 121 | 267 |
| Capital Expenditures | -92.2 | -55.6 | -22.5 | -130 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -259 | 238 | 27.6 | -43.7 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -351 | 182 | 5.15 | -173 |
| Financing Cash Flow Items | -6.23 | -21 | -14.5 | -37.1 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -60.1 | -23.7 | -276 | 421 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -259 | 252 | -144 | 500 |